Drugs for Neglected Diseases initiative (DNDi)
Marcel Tanner obtained a PhD in medical biology from the University of Basel and a MPH from the University of London. He is the President of the Swiss Academy of Sciences (SCNAT) since 2016. Previously – from 1997 until June 2015 – he was the Director of the Swiss Tropical and Public Health Institute. He is Professor and Chair of Epidemiology and Medical Parasitology at the University of Basel and at the Federal Institute of Technology.
Since 1977, his research ranges from basic research on the cell biology and immunology on malaria, schistosomiasis, trypanosomiasis and filariasis to epidemiological and public health research on risk assessment, vulnerability, health impact and district health planning. His research, teaching and health planning expertise are based on substantial long term experience from working in rural and urban areas in Africa (mainly Tanzania, Chad, Burkina Faso and Côte d’Ivoire) and Asia (China, Thailand, Laos).
Professor Tanner was co-investigator and coordinator of the first African malaria vaccine trial in 1992 and participated as co-principal investigator in several major intervention trials on malaria (iron supplementation, intermittent preventive treatment) and schistosomiasis. Besides research the capacity building and North-South partnership was a main interest as reflected in the development of the Ifakara Health Institute in Tanzania.
He has published extensively in the many fields (>500 original papers). He also acted and acts as advisor on communicable diseases research and control, health systems strengthening and capacity building in various national and international agencies / bodies and on boards/committees such as e.g. WHO/STAC-TDR, Wellcome Trust, DNDi, NITD, INCLEN-Trust and INEPTH.